Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

SCARF-1 promotes adhesion of CD4+ T cells to human hepatic sinusoidal endothelium under conditions of shear stress.

Patten DA, Kamarajah SK, Rose JM, Tickle J, Shepherd EL, Adams DH, Weston CJ, Shetty S.

Sci Rep. 2017 Dec 14;7(1):17600. doi: 10.1038/s41598-017-17928-4.

2.

Hypoxia serves a key function in the upregulated expression of vascular adhesion protein‑1 in vitro and in a rat model of hemorrhagic shock.

Zhang Y, Yi W, Yao J, Yu X, Qian C, Hu Z.

Mol Med Rep. 2017 Aug;16(2):1189-1199. doi: 10.3892/mmr.2017.6727. Epub 2017 Jun 8.

3.

The three Rs: Recruitment, Retention and Residence of leukocytes in the liver.

McNamara HA, Cockburn IA.

Clin Transl Immunology. 2016 Dec 30;5(12):e123. doi: 10.1038/cti.2016.84. eCollection 2016 Dec. Review.

4.

Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.

Horváth Á, Menghis A, Botz B, Borbély É, Kemény Á, Tékus V, Csepregi JZ, Mócsai A, Juhász T, Zákány R, Bogdán D, Mátyus P, Keeble J, Pintér E, Helyes Z.

Sci Rep. 2017 Jan 9;7:39863. doi: 10.1038/srep39863.

5.

Mechanisms of T cell organotropism.

Fu H, Ward EJ, Marelli-Berg FM.

Cell Mol Life Sci. 2016 Aug;73(16):3009-33. doi: 10.1007/s00018-016-2211-4. Epub 2016 Apr 1. Review.

6.

Direct evidence for activated CD8+ T cell transmigration across portal vein endothelial cells in liver graft rejection.

Kariya T, Ueta H, Xu XD, Koga D, Ezaki T, Yu E, Kusumi S, Kitazawa Y, Sawanobori Y, Ushiki T, Issekutz T, Matsuno K.

J Gastroenterol. 2016 Oct;51(10):985-98. doi: 10.1007/s00535-016-1169-1. Epub 2016 Feb 18.

7.

Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?

Torok NJ.

Hepatology. 2015 Oct;62(4):1313-5. doi: 10.1002/hep.27942. Epub 2015 Jul 31. No abstract available.

8.

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.

Weston CJ, Shepherd EL, Claridge LC, Rantakari P, Curbishley SM, Tomlinson JW, Hubscher SG, Reynolds GM, Aalto K, Anstee QM, Jalkanen S, Salmi M, Smith DJ, Day CP, Adams DH.

J Clin Invest. 2015 Feb;125(2):501-20. doi: 10.1172/JCI73722. Epub 2014 Dec 22.

9.

WSX-1 signalling inhibits CD4⁺ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways.

Villegas-Mendez A, Gwyer Findlay E, de Souza JB, Grady LM, Saris CJ, Lane TE, Riley EM, Couper KN.

PLoS One. 2013 Nov 7;8(11):e78486. doi: 10.1371/journal.pone.0078486. eCollection 2013.

10.

Effector CD8 T cell trafficking within the liver.

Guidotti LG, Iannacone M.

Mol Immunol. 2013 Aug;55(1):94-9. doi: 10.1016/j.molimm.2012.10.032. Epub 2012 Nov 10. Review.

11.

Liver restores immune homeostasis after local inflammation despite the presence of autoreactive T cells.

Béland K, Lapierre P, Djilali-Saiah I, Alvarez F.

PLoS One. 2012;7(10):e48192. doi: 10.1371/journal.pone.0048192. Epub 2012 Oct 24.

12.

Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.

Cripps JG, Celaj S, Burdick M, Strieter RM, Gorham JD.

Lab Invest. 2012 Oct;92(10):1461-71. doi: 10.1038/labinvest.2012.104. Epub 2012 Aug 20.

13.

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities.

Pardee AD, Butterfield LH.

Oncoimmunology. 2012 Jan 1;1(1):48-55.

14.

Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.

Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S.

Blood. 2011 Sep 29;118(13):3725-33. doi: 10.1182/blood-2010-09-311076. Epub 2011 Aug 5.

15.

Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity.

Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH.

Hepatology. 2011 Feb;53(2):661-72. doi: 10.1002/hep.24085. Epub 2011 Jan 10.

16.

CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium.

Aspinall AI, Curbishley SM, Lalor PF, Weston CJ, Blahova M, Liaskou E, Adams RM, Holt AP, Adams DH.

Hepatology. 2010 Jun;51(6):2030-9. doi: 10.1002/hep.23591.

17.

Mechanisms of immune-mediated liver injury.

Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H.

Toxicol Sci. 2010 Jun;115(2):307-21. doi: 10.1093/toxsci/kfq009. Epub 2010 Jan 13. Review.

18.

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME.

Semin Immunopathol. 2009 Sep;31(3):309-22. doi: 10.1007/s00281-009-0167-2. Epub 2009 Jun 17. Review.

19.

The immunobiology of primary sclerosing cholangitis.

Aron JH, Bowlus CL.

Semin Immunopathol. 2009 Sep;31(3):383-97. doi: 10.1007/s00281-009-0154-7. Epub 2009 May 26. Review.

20.

Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis.

Shetty S, Lalor PF, Adams DH.

Toxicology. 2008 Dec 30;254(3):136-46. doi: 10.1016/j.tox.2008.08.003. Epub 2008 Aug 19. Review.

Supplemental Content

Support Center